Funds and ETFs Novacyt

Equities

ALNOV

FR0010397232

Biotechnology & Medical Research

Real-time Euronext Paris 06:09:05 2024-03-28 am EDT 5-day change 1st Jan Change
0.5185 EUR +0.68% Intraday chart for Novacyt +1.87% -27.28%
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors: - development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests; - manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
More about the company

Annual profits - Rate of surprise